1. Home
  2. AUID vs HOWL Comparison

AUID vs HOWL Comparison

Compare AUID & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.10

Market Cap

18.4M

Sector

Technology

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.32

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
HOWL
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
AUID
HOWL
Price
$1.10
$0.32
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
107.9K
647.6K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
18.40
EPS
N/A
N/A
Revenue
$2,040,660.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
130.20
N/A
52 Week Low
$0.84
$0.33
52 Week High
$5.82
$2.23

Technical Indicators

Market Signals
Indicator
AUID
HOWL
Relative Strength Index (RSI) 45.54 30.92
Support Level $0.93 N/A
Resistance Level $1.13 $0.74
Average True Range (ATR) 0.09 0.04
MACD -0.01 0.01
Stochastic Oscillator 32.14 8.15

Price Performance

Historical Comparison
AUID
HOWL

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: